SCHEMBL6589803

SCHEMBL6589803

Cc1ccc(N)c(C(=O)Nc2ccc(Cl)cc2)c1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 3/20 0.58
F10 P00742 6/20 0.57
MAOB P27338 2/20 0.55
F12 P00748 1/20 0.55
HDAC1 Q13547 2/20 0.55
BRAF P15056 1/20 0.55
HDAC8 Q9BY41 2/20 0.55
HDAC6 Q9UBN7 1/20 0.55
P2RX1 P51575 2/20 0.53
TMPRSS4 Q9NRS4 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
F2 P00734 1/20 0.50
PLAU P00749 1/20 0.50
PLAT P00750 1/20 0.50
GCK P35557 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11746736 0.91 PLAU (0.55) F10MAOBF12MEN1KMT2A
SCHEMBL6587131 0.87 FADS1 (0.74) FADS1HDAC1BRAFP2RX1TMPRSS4
SCHEMBL6592828 0.85 MAPT (0.61) F10MEN1KMT2AMAPTMAPK1
SCHEMBL6594953 0.84 MEN1 (0.59) FADS1MAOBF12MEN1KMT2A
SCHEMBL18160306 0.84 HDAC8 (0.68) F10MAOBF12HDAC1HDAC8
SCHEMBL24460276 0.83 P2RX1 (0.77) F10MAOBF12P2RX1TMPRSS4
SCHEMBL5222453 0.82 RAF1 (0.60) HDAC1BRAFHDAC8MEN1KMT2A
SCHEMBL799808 0.82 RAB9A (0.63) F10MEN1KMT2AMAPT
SCHEMBL6594140 0.82 FADS1 (0.72) FADS1F10HDAC1BRAFP2RX1
SCHEMBL10243995 0.81 FADS1 (0.57) FADS1F10HDAC1BRAFHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143855-C I (ortho)-anthranilamide derivatives as anti-coagulants ���ֹɷݹ�˾ 2004-03-31 CN disclosed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
CN-1282329-A I (ortho)-anthranilamide derivatives as anti-coagulants SCHERING AG (DE) 2001-01-31 CN disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed